BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vazzana N, Santilli F, Lattanzio S, Liani M, Giacci L, Del Rosso G, Salvati F, Boccatonda A, Ferroni P, Davì G. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease. Eur J Intern Med 2016;33:74-80. [PMID: 27389698 DOI: 10.1016/j.ejim.2016.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Violi F, Targher G, Vestri A, Carnevale R, Averna M, Farcomeni A, Lenzi A, Angelico F, Cipollone F, Pastori D. Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design. Am Heart J 2017;189:120-7. [PMID: 28625368 DOI: 10.1016/j.ahj.2017.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Guo J, Wang J, Feng J. Aspirin resistance mediated by oxidative stress-induced 8-Isoprostaglandin F2. J Clin Pharm Ther 2019;44:823-8. [PMID: 30989683 DOI: 10.1111/jcpt.12838] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Simeone P, Boccatonda A, Liani R, Santilli F. Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis. Ageing Res Rev 2018;48:51-78. [PMID: 30273676 DOI: 10.1016/j.arr.2018.09.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
4 Xu YJ, Zheng Z, Cao C, Li J, Liu Y. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinoma. Cancer Metastasis Rev 2018;37:269-77. [PMID: 29934821 DOI: 10.1007/s10555-018-9747-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Cecerska-Heryć E, Heryć R, Wiśniewska M, Serwin N, Grygorcewicz B, Dołęgowska B. Effect of renal replacement therapy on selected arachidonic acid derivatives concentration. BMC Nephrol 2020;21:394. [PMID: 32917166 DOI: 10.1186/s12882-020-02053-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Conway EA, Evans NP, Ridyard AE. Urinary 11-dehydrothromboxane B2 concentrations in 20 dogs with primary immune-mediated hemolytic anemia. J Vet Intern Med 2021. [PMID: 34859495 DOI: 10.1111/jvim.16322] [Reference Citation Analysis]
7 Pignatelli P, Pastori D, Bartimoccia S, Menichelli D, Vicario T, Nocella C, Carnevale R, Violi F. Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding. Pharmacol Res 2016;113:484-9. [PMID: 27693274 DOI: 10.1016/j.phrs.2016.09.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
8 Florens N, Calzada C, Lemoine S, Boulet MM, Guillot N, Barba C, Roux J, Delolme F, Page A, Poux JM, Laville M, Moulin P, Soulère L, Guebre-Egziabher F, Juillard L, Soulage CO. CKD Increases Carbonylation of HDL and Is Associated with Impaired Antiaggregant Properties. J Am Soc Nephrol 2020;31:1462-77. [PMID: 32518085 DOI: 10.1681/ASN.2019111205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Idborg H, Pawelzik S. Prostanoid Metabolites as Biomarkers in Human Disease. Metabolites 2022;12:721. [DOI: 10.3390/metabo12080721] [Reference Citation Analysis]